Literature DB >> 8662035

Fetal idiopathic ventricular tachycardia with nonimmune hydrops: benign course.

L M Lopes1, S C Cha, M I Scanavacca, V M Tuma-Calil, M Zugaib.   

Abstract

A case of idiopathic ventricular tachycardia of left ventricular origin in a hydropic fetus is presented. The accuracy of fetal echocardiography for diagnosing this type of arrhythmia is emphasized, as is its importance in determining appropriate postnatal treatment which in this case resulted in an unusually benign course.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662035     DOI: 10.1007/BF02505212

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  6 in total

1.  Idiopathic sustained left ventricular tachycardia: clinical and electrophysiologic characteristics.

Authors:  T Ohe; K Shimomura; N Aihara; S Kamakura; M Matsuhisa; I Sato; H Nakagawa; A Shimizu
Journal:  Circulation       Date:  1988-03       Impact factor: 29.690

2.  Prospective study of fetal heart rate and rhythm patterns.

Authors:  D P Southall; J Richards; R A Hardwick; E A Shinebourne; G L Gibbens; H Thelwall-Jones; M de Swiet; P G Johnston
Journal:  Arch Dis Child       Date:  1980-07       Impact factor: 3.791

Review 3.  Fetal cardiac arrhythmias.

Authors:  L Shenker
Journal:  Obstet Gynecol Surv       Date:  1979-08       Impact factor: 2.347

4.  Recognition of fetal arrhythmias by echocardiography.

Authors:  N H Silverman; M A Enderlein; P Stanger; D F Teitel; M A Heymann; M S Golbus
Journal:  J Clin Ultrasound       Date:  1985-05       Impact factor: 0.910

5.  Fetal ventricular tachycardia associated with nonimmunologic hydrops fetalis. A case report.

Authors:  D M Sherer; E Sadovksy; M Menashe; N Mordel; A J Rein
Journal:  J Reprod Med       Date:  1990-03       Impact factor: 0.142

6.  Treatment of fetal supraventricular tachyarrhythmias.

Authors:  C S Kleinman; J A Copel; E M Weinstein; T V Santulli; J C Hobbins
Journal:  J Clin Ultrasound       Date:  1985-05       Impact factor: 0.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.